SeqLL, Inc.
Biotechnology company · Woburn, Massachusetts, United States
SeqLL, Inc. is a biotechnology company headquartered in Woburn, Massachusetts, United States. Its earliest recorded incorporation is in 2014. It has received 1 US government small-business research award (SBIR/STTR) from health agencies, $223,465 in total, most recently in 2017. It has reported private securities offerings to the US SEC, most recently $120,000 sold in a notice filed in 2018.
SeqLL at a glance
What does SeqLL do?
US government research funding
1 SBIR/STTR small-business research award from US health agencies, $223,465 in total (2017). NIH funding came from the National Human Genome Research Institute.
Private fundraising reported to the SEC
3 Form D notices; the most recent reported $120,000 sold (2018).
Frequently asked questions about SeqLL
Where is SeqLL headquartered?
SeqLL, Inc. is headquartered in Woburn, Massachusetts, United States.
What does SeqLL do?
SeqLL, Inc. is a biotechnology company.
When was SeqLL founded?
The earliest incorporation on record for SeqLL, Inc. is in 2014, according to public company registers.
Similar companies
- ImmunoMolecular Therapeutics, Inc.Woburn, Massachusetts, United States
- Hearthstone Alzheimer Care Ltd.Woburn, Massachusetts, United States
- PNA Innovations, Inc.Woburn, Massachusetts, United States
- Terrestrial Bio, Inc.Woburn, Massachusetts, United States
- Alloplex Biotherapeutics, Inc.Woburn, Massachusetts, United States
- Replimune Group, Inc.Woburn, Massachusetts, United States
- Neurogastrx, Inc.Woburn, Massachusetts, United States
- Sirtex Medical Inc.Woburn, Massachusetts, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-23. Data licences